Abbas Ali Mansour,
MD, Department of Medicine, Basrah
College of Medicine
Husam Jihad Imran, MBCHB, Department
of Medicine Basrah General Hospital
|
Background:
Diabetic foot abnormalities are clearly
one of the most important complications
of diabetes mellitus (DM) and the
leading cause of hospitalization with
substantial morbidity, impairment
of quality of life, and engender high
treatment costs. The aim of this study
was to estimate the prevalence of
diabetic foot abnormalities among
patients with type 2 DM and the predictors
of these abnormalities in Basrah.
Patients and
methods: This was a cross sectional
study of patients attending the out
patient clinic of two hospitals in
Basrah (the General and the Teaching)
for the period from January to the
end of December 2005. All patients
had type 2 DM.
Results: The
total number of patients was 182 (80
males and 102 females). Diabetic foot
abnormalities were reported in 46.7%
of patients. Most patients had more
than one abnormality. Structural foot
abnormalities reported in diabetic
patients were prominent metatarsal
heads in 36.2%, wasting in 11.5% hammer
toes in 10.9%, pes cavus in 5.4%,
claw toes in 3.8%, and amputees in
2.1%. While skin changes included
dryness of the skin in 17%, fissures
in the skin in 14.7%, callosities
in 14.2%, Tinea pedis in 13.7%, foot
ulcer in 13.7% and nail changes in
7.1%. Peripheral neuropathy and dermopathy
were seen in 21.9% and 6% respectively.
Conclusions:
Variables predicting foot abnormalities
were higher age, male sex, less school
achievement, longer duration of DM,
higher BMI, smoking history, low social
class, insulin use, hypertension,
heart failure and proteinuria.
Key words:
diabetic foot, ulcer, prevalence,
Basrah
|
Diabetic foot abnormalities
are clearly one of the most important complications
of diabetes mellitus (DM) and the leading
cause of hospitalization with substantial
morbidity, impairment of quality of life,
and high treatment costs .1,2 It not only
occurs as a typical complication in the
late stages of diabetes but also in patients
with newly diagnosed DM.
Motor neuropathy
leads to muscle atrophy, foot deformity,
altered biomechanics of walking, and redistribution
of foot pressures during standing and walking,
which lead to callus. 3,4 Abundant callus
formation on pressure points (which act
like a foreign body and further increase
pressure) together with thinning of the
submetatarsal head fat-pads, additionally
increases the force of plantar pressure
and ultimately results in foot ulceration.
The risk of ulceration
is proportional to the number of risk factors.
The risk is increased by 1.7 in persons
with isolated peripheral neuropathy, by
12 in those with peripheral neuropathy and
foot deformity, and by 36 in those with
peripheral neuropathy, deformity, and previous
amputation, as compared with persons without
risk factors.5
In developing countries,
which will experience the greatest rise
in the prevalence of type 2 DM in the next
20 years, people at greatest risk of ulceration
can easily be identified by careful clinical
examination of the feet. Education and frequent
follow-up is indicated for these patients.6
As the world is facing an epidemic of type
2 DM and an increasing incidence of type
1 DM, the International Diabetes Federation
has chosen to focus on the global burden
of diabetic foot disease in 2005.
Data on diabetic foot
in Iraq are scanty and anecdotal.7
The aim of this study
was to estimate the prevalence of diabetic
foot abnormalities among patients with type
2 DM and the predictors of these abnormalities
in Basrah.
This was a cross sectional
study of patients attending the out patient
clinic of two hospitals in Basrah (the General
and the Teaching) for the period from January
to the end of December 2005.All patients
had type 2 DM. Diabetes and hypertension
was defined as self-reported physician diagnosis
of diabetes and hypertension.8
For all patients history
was taken including age of the patients,
smoking status, job, and qualifications
(years of school achievement). Social class
was calculated,and each patient was classified
into low and other socioeconomic status,
based on the aggregate score of education,
occupation, and income.9 They were asked
about duration of diabetes, medications,
hospitalization and previous diabetic foot
problems. Subjects reporting smoking at
least one cigarette per day during the year
before the examination were classified as
smokers. All patients were examined for
weight, height, blood pressure, body mass
index (BMI), and calculated according to
Quetelet formula (weight in kilograms divided
by height in metres squared). Skin and peripheral
pulsation were examined .Both feet were
examined for structural foot abnormalities
and skin changes.
Structural foot abnormalities
were defined as follows: prominent metatarsal
heads were defined as "any palpable
plantar prominences of the metatarsal site
of the foot," and high medial arch
(pes cavus) as "an abnormally high
medial longitudinal arch, which extends
between the first metatarsal head and the
calcaneus". 4,10,11 Extension contracture
at the metatarsophalangeal (MTP) joint with
flexion contracture at the proximal interphalangeal
(PIP) joint is called hammer toe, while
hyperextension of the MTP and flexion of
the PIP and distal interphalangeal (DIP)
joint is termed a claw toe. Wasting was
considered when there is guttering between
metatarsal heads.
Skin was examined for
callus which was defined as any hyperkeratotic
formation due to shear stresses, usually
in proximity to a bony prominence. Dryness
was assessed objectively; fissures were
included as any skin break that does not
fit for the definition of foot ulcer below.
Nail changes included any longitudinal ridging,
fissuring, separations, loss or thickening.4,10,11
Diabetic foot ulcer was defined as any full-thickness
skin lesion distal to the ankle excluding
minor abrasions, fissures or blisters. Interdigital
fungal infection (Tinea pedis) was considered
as any white, macerated skin between any
web spaces.12
|
|
Metabolic control was
according to American Diabetes Association
(ADA) with fasting plasma glucose of 90-130
(5.0-7.2) mg/dL (mmol/L) and postprandial
plasma glucose of less than 180 (< 10.0)
mg/dL (mmol/L).13 An average
of at least 3 readings were taken.
Diagnosis of peripheral neuropathy was according
to quantitive assessment of symptoms and
physical finding according to others' practice.14
Electrocardiography (ECG)
was done for all and urine examined for
overt proteinuria. Proteinuria was diagnosed
on the basis of persistent frank proteinuria
without erythrocytes or white blood cells
in urine. Electrocardiographic changes were
considered according to practice.15
Heart failure diagnosis
was based on history and physician diagnosis
with echocardiography.
Continuous variables
were summarized as the mean ± SD.
Categoric variables were summarized as percentages.
For statistical analysis a chi-square test
was used. A comparison of 2 means was carried
out with an unpaired Student t test. The
level of significance was set to be <
0.05 throughout the analysis.
The total number of patients
was 182 (80 males and 102 females), with
mean age of 56±8.4 year, and qualification
of 2.5 ±4 year ( table-1).
Duration of DM was 7.6±6.1 year and
BMI of 25.6±2.5. Sixty eight point
six percent were non- employed and 77.4%
were from a rural area. Most subjects were
from a low social class (86.8%). Their treatment
was diet with oral hypoglycemic drugs in
73.6% and most had non-optimal glycemic
control (94.5%) according to ADA. Hypertension
was present in 52.1% with heart failure
in 20.8%, ECG changes in 63.7% and proteinuria
in 26.3%.
Structural foot abnormalities
reported in diabetic patients were prominent
metatarsal heads in 36.2%, wasting in 11.5%,
hammer toes in 10.9%, pes cavus in 5.4%,
claw toes in 3.8%, and amputees in 2.1%
(table-2).
While skin changes included dryness of the
skin in 17%, fissures in the skin in 14.7%,
callosities in 14.2%, Tinea pedis in 13.7%,
foot ulcer in 13.7%, and nail changes in
7.1%. Peripheral neuropathy and dermopathy
was seen in 21.9% and 6% respectively.
Diabetic foot abnormalities
were reported in 46.7% of patients (table-3).
Most patients had more than one abnormality.
Variables that predict foot abnormalities
(statistically significant) were higher
age, male sex, less school achievement,
longer duration of DM, higher BMI, smoking
history, low social class, insulin use,
hypertension, heart failure, and proteinuria.
Foot abnormalities were
reported in 46.7% in this study with mean
age of 62±6.2 year. A population
based study in Minnesota showed that most
diabetic patients have foot problems after
age 40 and that the incidence of these problems
increases with age.16
The commonest structural
foot abnormalities in our study were prominent
metatarsal heads (36.2%), followed by wasting
(11.5%), then hammer toes (10.9%) and claw
toes (3.8%).These changes alter foot biomechanics
which will increase risk of ulceration and
amputation.17
In this study diabetic
foot ulcer was present in 13.7% of patients.
This alarmingly high figure, is comparable
with the figure (11.9%) in Algeria.18
To complicate the story of diabetic foot
care in our area, we have no podiatry services
available and since amputations are preceded
by foot ulcers in 75-85% of cases.6
These figures seems amazing, for the future
amputation in our diabetics.
Commonest skin changes
in the study were dryness of the skin followed
by fissures in the skin and callosities.
The explanation of these skin changes is
autonomic neuropathy which is reflected
by decreased sweating, loss of skin temperature
regulation, and autosympathectomy. Anhydrosis
results in xerotic skin and predisposes
skin to fissures, cracks, and callus formation.19
Predictors of foot abnormalities
in this study were higher age, male sex,
less school achievement, longer duration
of diabetes mellitus, higher BMI, smoking
history, low social class, insulin use,
hypertension, heart failure and Proteinuria.
Similarly ADA consensus group found that
among persons with diabetes, the risk of
foot ulceration was increased among men,
patients who had had diabetes for more than
10 years, and patients with poor glucose
control or with cardiovascular, retinal,
or renal complications.17 And the benefit
of education in reducing diabetic foot ulcers
and lower-extremity amputation is well documented.20
In a large Italian case-control study possible
risk factors for ulcer formation were, male
sex, and lack of diabetes education.21
While in Jordan amputation of the lower
limbs correlates with duration of diabetes,
poor glycemic control, smoking, neurological
impairment, peripheral vascular disease
and microalbuminuria.22 Lavery et al, in
a multivariate model, have also demonstrated
that poor glucose control, duration of diabetes
over 10 years, and male sex are also significant
risk factors for foot ulceration.5
Diabetic foot abnormalities
were reported in 46.7% of patients. Variables
predicting foot abnormalities (statistically
significant) were higher age, male sex,
less school achievement, longer duration
of diabetes mellitus, higher BMI, smoking
history, low social class, insulin use,
hypertension, heart failure and proteinuria.
We are calling for organization of the foot-care
service in Basrah, and education should
be tailored to the patient's understanding
and social background to manage an epidemic
of foot abnormalities expected to be seen
in the near future.
|
1. |
New
JP, McDowell D, Burns E, Young RJ. Problem
of amputations in patients with newly
diagnosed diabetes mellitus. Diabet
Med .1998; 15:760-764. |
2. |
Boulton
AJ. The diabetic foot: a global view.
Diabetes Metab Res Rev 2000;16(suppl
1):S2-5. |
3. |
Pataky
Z, Golay A, Faravel L, Da Silva J, Makoundou
V, Peter-Riesch B, Assal JP. The impact
of callosities on the magnitude and
duration of plantar pressure in patients
with diabetes mellitus. Diabetes Metab
2002; 28: 356-361. |
4. |
Reiber
GE, Vileikyte L, Boyko EJ, del Aguila
M, Smith DG, Lavery LA, Boulton AJ.
Causal pathways for incident lower-extremity
ulcers in patients with diabetes from
two settings.Diabetes Care .1999;22:157-162
. |
5. |
Lavery
LA, Armstrong DG, Vela SA, Quebedeaux
TL, Fleischli JG. Practical criteria
for screening patients at high risk
for diabetic foot ulceration.Arch Intern
Med 1998;158:157-162. |
6. |
Boulton
AJM, Vileikyte L, Ragnarson-Tennvall
G, Apelqvist J. The global burden of
diabetic foot disease. Lancet 2005;
366: 1719-1724. |
7. |
Khoshnaw
AI. The diabetic foot in Iraq. Lancet.
2005; 366 :1718. |
8. |
Standards
of medical care for patients with diabetes
mellitus. American diabetes association.
Diabetes Care 2002;25: 213-229. |
9. |
Park
JE,Oark K.Text book of preventive and
social medicine .4th ed. Jabalpur:Banarsidas
Bahanot,1985,P 25-26. |
10. |
Boike
AM, Hall JO. A practical guide for examining
and treating the diabetic foot. Cleve
Clin J Med. 2002; 69:342-348. |
11. |
Birke
JA, Novick AC, Hawkins ES, Patout CA
Jr.A Review of Causes of Foot Ulceration
in Patients with Diabetes Mellitus.
JPO.1992 ;4: 13-22. |
|
|
12. |
Masri-Fridling
GD. Dermatophytosis of the feet. Dermatol
Clin 1996;14:33-40 . |
13. |
American
Diabetes Association. Summary of revisions
for the 2005 clinical practice recommendations.
Diabetes Care. 2005;28:S3. |
14. |
Young
MJ, Boulton AJM, Macleod AF,Williams
DRR, Sonksen PH. A multicenter study
of the prevalence of diabetic peripheral
neuropathy in the United Kingdom hospital
clinic population. Diabetologia 1993;36:150-154. |
15. |
Galens,
Wagner D. Marriott's Practical Electrocardiography
.10th ed. Philadelphia, Lippincott Williams
& Wilkins, 2000. |
16. |
Humphrey
LL, Ballard DJ, Butters PJ, et al. The
epidemiology of lower extremity amputation
in diabetics: a population-based study
in Rochester, Minnesota (Abstract).
Diabetes 1989; 2(suppl 2):33A. |
17. |
American
Diabetes Association. Preventive foot
care in people with diabetes. Diabetes
Care 1999;22:Suppl 1:S54-S55. |
18. |
Richard
J-L. Le pied diabétique: fréquence,
coût dépistage et prévention.
J Plaies Cicatrisations 1997; 7: 127-131. |
19. |
Murray
HJ, Boulton AJM. The pathophysiology
of diabetic foot ulceration. Clin Podiatr
Med Surg 1995;12:1-17. |
20. |
American
Diabetes Association: Consensus Development
Conference on Diabetic Foot Wound Care:
7-8 April 1999, Boston, Massachusetts.
Diabetes Care 1999; 22:1354-1360. |
21. |
el-Shazly
M, Abdel-Fattah M, Scorpiglione N, Benedetti
MM, Capani F, Carinci F, Carta Q, Cavaliere
D, De Feo EM, Taboga C, Tognoni G, Nicolucci
A.. Risk Factors for Lower Limb Complications
in Diabetic Patients. Journal of Diabetes
and Its Complications.1998; 12: 10-17. |
22. |
Jbour
AS, Jarrah NS, Radaideh AM, Shegem NS,
Bader IM, Batieha AM, Ajlouni KM. Prevalence
and predictors of diabetic foot syndrome
in type 2 diabetes mellitus in Jordan
.Saudi Med J. 2003; 24: 761-764. |
|